Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Susan A. White, S.A. Amali S. Subasinghe, Jonathan Romero, Jason T. Yustein, Robia G. Pautler, Matthew J. Allen, Md. Abul Hassan Samee
Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging. // Cancer Treatment and Research Communications. – URL: https://www.sciencedirect.com/science/article/pii/S2468294226004314?dgcid=rss_sd_all
Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging. Cancer Treatment and Research Communications. https://www.sciencedirect.com/science/article/pii/S2468294226004314?dgcid=rss_sd_all
“Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging.” Cancer Treatment and Research Communications.
@article{article39589,
title = {Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging},
journal = {Cancer Treatment and Research Communications},
url = {https://www.sciencedirect.com/science/article/pii/S2468294226004314?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment